レナサイエンスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/12/02 | 1,900 | 1,918 | 1,772 | 1,775 | -135 | -7.1% | 813,700 |
| 2025/12/01 | 1,944 | 2,062 | 1,892 | 1,910 | -310 | -14% | 1,599,100 |
| 2025/11/28 | 1,983 | 2,228 | 1,977 | 2,220 | +223 | +11.2% | 954,100 |
| 2025/11/27 | 2,006 | 2,015 | 1,960 | 1,997 | +71 | +3.7% | 285,900 |
| 2025/11/26 | 1,878 | 1,935 | 1,860 | 1,926 | +64 | +3.4% | 225,900 |
| 2025/11/25 | 1,885 | 1,896 | 1,843 | 1,862 | +2 | +0.1% | 126,600 |
| 2025/11/21 | 1,860 | 1,901 | 1,837 | 1,860 | -80 | -4.1% | 236,200 |
| 2025/11/20 | 1,930 | 1,960 | 1,903 | 1,940 | +90 | +4.9% | 291,900 |
| 2025/11/19 | 1,830 | 1,884 | 1,816 | 1,850 | +15 | +0.8% | 131,000 |
| 2025/11/18 | 1,890 | 1,927 | 1,835 | 1,835 | -55 | -2.9% | 210,600 |
| 2025/11/17 | 1,918 | 1,920 | 1,880 | 1,890 | -31 | -1.6% | 166,200 |
| 2025/11/14 | 1,972 | 2,022 | 1,895 | 1,921 | -83 | -4.1% | 378,900 |
| 2025/11/13 | 2,007 | 2,048 | 1,983 | 2,004 | +37 | +1.9% | 248,600 |
| 2025/11/12 | 1,971 | 2,045 | 1,961 | 1,967 | -32 | -1.6% | 264,200 |
| 2025/11/11 | 1,938 | 2,030 | 1,910 | 1,999 | +81 | +4.2% | 316,600 |
| 2025/11/10 | 1,911 | 1,941 | 1,883 | 1,918 | +11 | +0.6% | 133,900 |
| 2025/11/07 | 1,940 | 1,964 | 1,896 | 1,907 | -73 | -3.7% | 172,400 |
| 2025/11/06 | 1,950 | 2,009 | 1,929 | 1,980 | +31 | +1.6% | 193,200 |
| 2025/11/05 | 1,895 | 1,965 | 1,829 | 1,949 | +26 | +1.4% | 252,100 |
| 2025/11/04 | 1,878 | 1,934 | 1,860 | 1,923 | +26 | +1.4% | 220,300 |
| 2025/10/31 | 1,837 | 1,904 | 1,837 | 1,897 | +60 | +3.3% | 168,600 |
| 2025/10/30 | 1,810 | 1,891 | 1,781 | 1,837 | +23 | +1.3% | 214,400 |
| 2025/10/29 | 1,878 | 1,882 | 1,807 | 1,814 | -72 | -3.8% | 275,700 |
| 2025/10/28 | 1,930 | 1,947 | 1,870 | 1,886 | -39 | -2% | 269,200 |
| 2025/10/27 | 1,951 | 2,004 | 1,901 | 1,925 | -16 | -0.8% | 332,800 |
| 2025/10/24 | 1,959 | 1,986 | 1,923 | 1,941 | +18 | +0.9% | 254,600 |
| 2025/10/23 | 1,940 | 1,970 | 1,890 | 1,923 | -48 | -2.4% | 367,000 |
| 2025/10/22 | 1,911 | 2,026 | 1,901 | 1,971 | +50 | +2.6% | 554,900 |
| 2025/10/21 | 1,920 | 1,940 | 1,842 | 1,921 | +29 | +1.5% | 485,200 |
| 2025/10/20 | 1,890 | 1,923 | 1,832 | 1,892 | +42 | +2.3% | 369,200 |
| 2025/10/17 | 2,026 | 2,050 | 1,802 | 1,850 | -235 | -11.3% | 1,031,900 |
| 2025/10/16 | 1,985 | 2,103 | 1,941 | 2,085 | +70 | +3.5% | 802,400 |
| 2025/10/15 | 2,131 | 2,174 | 2,001 | 2,015 | -154 | -7.1% | 911,500 |
| 2025/10/14 | 2,222 | 2,270 | 2,100 | 2,169 | -111 | -4.9% | 1,329,100 |
| 2025/10/10 | 1,930 | 2,320 | 1,924 | 2,280 | +360 | +18.8% | 4,928,700 |
| 2025/10/09 | 1,845 | 1,988 | 1,801 | 1,920 | +28 | +1.5% | 1,618,400 |
| 2025/10/08 | 2,320 | 2,342 | 1,850 | 1,892 | -142 | -7% | 4,902,100 |
| 2025/10/07 | 2,034 | 2,034 | 2,034 | 2,034 | +400 | +24.5% | 26,900 |
| 2025/10/06 | 1,677 | 1,677 | 1,611 | 1,634 | +26 | +1.6% | 284,900 |
| 2025/10/03 | 1,599 | 1,631 | 1,572 | 1,608 | -12 | -0.7% | 347,400 |
| 2025/10/02 | 1,575 | 1,649 | 1,502 | 1,620 | +43 | +2.7% | 1,232,700 |
| 2025/10/01 | 1,671 | 1,765 | 1,560 | 1,577 | -119 | -7% | 982,000 |
| 2025/09/30 | 1,630 | 1,731 | 1,610 | 1,696 | +55 | +3.4% | 651,700 |
| 2025/09/29 | 1,732 | 1,765 | 1,610 | 1,641 | -163 | -9% | 1,048,300 |
| 2025/09/26 | 1,780 | 1,921 | 1,738 | 1,804 | +175 | +10.7% | 3,449,000 |
| 2025/09/25 | 2,122 | 2,122 | 1,629 | 1,629 | -500 | -23.5% | 1,160,900 |
| 2025/09/24 | 2,050 | 2,170 | 2,003 | 2,129 | +93 | +4.6% | 484,700 |
| 2025/09/22 | 2,039 | 2,079 | 2,003 | 2,036 | +22 | +1.1% | 271,500 |
| 2025/09/19 | 1,970 | 2,059 | 1,962 | 2,014 | +69 | +3.5% | 506,400 |
| 2025/09/18 | 1,963 | 1,983 | 1,905 | 1,945 | -7 | -0.4% | 227,500 |
1～
50
件表示中 / 1026件
類似銘柄と比較する
現在ご覧いただいている「レナサイエンス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| レナサイエンス | 171,300円 | +0.8% | - | 0.00% | - | 13.89倍 |
|
東北大発創薬ベンチャー。創業者の宮田同大教授が発見した低分子化合物を使い治療薬を開発 |
| ラクオリア | 134,200円 | +25.1% | - | 0.00% | - | 5.25倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
| アンジェス | 6,700円 | +36.9% | - | 0.00% | - | 7.78倍 |
|
大阪大医学部、森下竜一教授創業の創薬ベンチャー。遺伝子治療薬を核に核酸医薬など開発多彩 |
| 扶桑薬 | 216,400円 | +1.6% | -12.7% | 4.16% | 8.04倍 | 0.54倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ステムリム | 25,300円 | - | - | 0.00% | - | 2.68倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
市場注目の銘柄
チャート関連のコラム
